Official Title
Neurological Dry Eye Study Stimulating Both Lacrimal and Vagus Nerves
Brief Summary

This is a study on neurological dry eye disease, focusing on a patented over-the-countersupplement supporting tear production neurologically, including the lacrimal and vagusnerves.

Detailed Description

Chronic inflammation is implicated in the majority of chronic dry eyes. The
parasympathetic nervous system is responsible for both basal tear secretion (the aqueous
layer) by the lacrimal functional unit, and is responsible for controlling many aspects
of chronic inflammation via the vagus nerve.

This study will document its effects on dry eyes, in addition to other symptoms/signs of
low parasympathetic nervous system functioning using an over-the-counter supplement.

Not yet recruiting
Dry Eye Disease
Dry Eye

Dietary Supplement: NeuroTears

Over-the-counter supplement

Dietary Supplement: Placebo

Oral placebo pill

Eligibility Criteria

Inclusion Criteria:

- Must have dry eye (OSDI score 30 and above)

- Tear break up time of less than or equal to 7 seconds

- Must be able to come for baseline tests and again at 4 weeks

Exclusion Criteria:

- Demodex

- Corneal scarring

- must not take Physostigmine (glaucoma), Pyridostigmine (Mestinon), Neostigmine (for
Myasthenia Gravis); Aricept (for Alzheimer's), or ingredients to NeuroTears

- No known allergies to ingredients in NeuroTears

Eligibility Gender
All
Eligibility Age
Minimum: 20 Years ~ Maximum: 65 Years
Locations

Not Provided

Contacts

Diana Driscoll, OD
866-349-9905
orders@neurotears.com

Not Provided

Genetic Disease Investigators
NCT Number
Keywords
Vagus Nerve
Ehlers-Danlos Syndrome
EDS
lacrimal nerves
dry eye
tear production
Dysautonomia
POTS
Postural Orthostatic Tachycardia Syndrome
constipation
gastroparesis
Tachycardia
NeuroTears
Mast Cell Activation Syndrome
vagus nerve stimulation
MCAS
Post-COVID
Covid
Longhaulers
MeSH Terms
Dry Eye Syndromes
Keratoconjunctivitis Sicca
Eye Diseases